Medium 4.9Published Dec 18, 2025

CVE-2025-68463Bio.Entrez in Biopython through 186 allows doctype XXE.

Updated under an hour ago (Oct 26, 2026, 12:50 PM ET)

Does this affect you?

It affects Biopython. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stack

Free account, 1 product

Every CVE for Biopython

Exploited in the last 30 days

Bio.Entrez in Biopython through 186 allows doctype XXE.

CVSS: 4.9 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:N/A:L
Weakness (CWE): CWE-611
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: mitre
NVD analysis: Deferred
Record last updated: May 8, 2026
First seen by InfoSec Signals: Oct 9, 2026

Affected products

Affected products

Biopython Biopython biopython:biopython (from the name)	through 186	CNA record

References

References

https://github.com/biopython/biopython/issues/5109
https://pypi.org/project/biopython/1.87/
https://github.com/biopython/biopython/blob/master/NEWS.rst
https://github.com/biopython/biopython/commit/736c96f37b190732ecca9da80ad0cb9d4967214d
http://www.openwall.com/lists/oss-security/2026/05/08/16

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.